Although previous case reports or small-sample studies have suggested that patients with anti-LGI1 encephalitis may experience cardiac or metabolic complications (19), the specific prevalence rates of HHCY and electrocardiographic abnormalities have not been widely quantified. This evidence concerns the gene LGI1 and encephalitis.